Kyntra Bio Long Term Deferred Assets (Quarterly) Analysis

Kyntra Bio, Inc. (KYNB)

8.83 +0.28 (+3.27%) USD | NASDAQ | Jan 21, 16:00

8.83 0.00 (0.00%) After-Hours: 16:26

View Long Term Deferred Assets (Quarterly) for KYNB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Assertio Holdings, Inc.	--
Perspective Therapeutics, Inc.	--
Skye Bioscience, Inc.	--
Theravance Biopharma, Inc.	--
Myomo, Inc.	--